Physician profile
Laurel Lan
NPI 1194831933
$2,112.37
in general payments reported to CMS, 2019-2025
20 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.99 · 2022: $56.28 · 2023: $188 · 2024: $613 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256 · Consulting Fee: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.10 |
| Consulting Fee | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $749.55 | 2025 | Sofdra |
| E.R. Squibb & Sons, L.L.C. | $195.48 | 2022-2024 | Sotyktu |
| Abbvie INC. | $186.15 | 2023-2025 | |
| Genzyme Corporation | $141.51 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $109.41 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $99.99 | 2021 | |
| Novartis Pharmaceuticals Corporation | $92.41 | 2023-2025 | |
| Lilly USA, LLC | $84.52 | 2022-2025 | Olumiant, Ebglyss |
| Ucb, INC. | $71.27 | 2024 | Bimzelx |
| Janssen Biotech, INC. | $67.48 | 2025 | Tremfya |
| Leo Pharma INC. | $54.25 | 2024-2025 | Adbry, Spevigo |
| Journey Medical Corporation | $46.62 | 2025 | |
| Incyte Corporation | $43.80 | 2022-2023 | Opzelura |
| Organon LLC | $40.35 | 2025 | Vtama |
| Galderma Laboratories, L.P. | $30.95 | 2024-2025 | Nemluvio |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $23.83 | 2024 | Klisyri |
| Dermavant Sciences, INC. | $23.37 | 2024 | Vtama |
| Pfizer INC. | $20.32 | 2024 | |
| Arcutis Biotherapeutics, INC. | $16.47 | 2024 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.64 | 2024 | Cabtreo, Arazlo, Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Lan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.